These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6822028)

  • 1. Effect of phenoxybenzamine on cardiovascular and plasma catecholamine responses to clonidine.
    Zweifler A; Gross M; Sisson J
    Clin Pharmacol Ther; 1983 Feb; 33(2):156-62. PubMed ID: 6822028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clonidine on central and peripheral nerve tone in primary hypertension.
    Sullivan PA; De Quattro V; Foti A; Curzon G
    Hypertension; 1986 Jul; 8(7):611-7. PubMed ID: 3721561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diuretic treatment alters clonidine suppression of plasma norepinephrine.
    Hui TP; Krakoff LR; Felton K; Yeager K
    Hypertension; 1986 Apr; 8(4):272-6. PubMed ID: 3514447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular, humoral, and renal effects of phenoxybenzamine in hypertension.
    Ganguly A; Weinberger MH; Fineberg NS
    Am J Kidney Dis; 1983 Mar; 2(5):534-43. PubMed ID: 6299099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and catecholamine response to clonidine in obese subjects.
    Del Rio G; Zizzo G; Bonati ME; Macdonald IA; Velardo A
    Int J Obes Relat Metab Disord; 1995 Jul; 19(7):475-9. PubMed ID: 8520637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction.
    Gross MD; Shapiro B; Sisson JC; Zweifler A
    J Endocrinol Invest; 1987 Aug; 10(4):359-64. PubMed ID: 2890683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
    Veith RC; Best JD; Halter JB
    J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal phenomena in subjects with essential hypertension on clonidine or tiamenidine.
    Hamilton BP; Mersey JH; Hamilton J; Kuzbida G; Pavlis R; Levinson P
    Clin Pharmacol Ther; 1984 Nov; 36(5):628-33. PubMed ID: 6488684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved safety of glucagon testing for pheochromocytoma by prior alpha-receptor blockade. A controlled trial in a patient with a mixed ganglioneuroma/pheochromocytoma.
    Elliott WJ; Murphy MB; Straus FH; Jarabak J
    Arch Intern Med; 1989 Jan; 149(1):214-6. PubMed ID: 2912409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma.
    Mannelli M; De Feo ML; Maggi M; Pupilli C; Opocher G; Valenza T; Baldi E; Serio M
    J Endocrinol Invest; 1987 Aug; 10(4):377-82. PubMed ID: 2890684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in catecholamine response to clonidine.
    Del Rio G; Verlardo A; Zizzo G; Marrama P; Della Casa L
    Int J Obes Relat Metab Disord; 1993 Aug; 17(8):465-9. PubMed ID: 8401749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon and clonidine testing in the diagnosis of pheochromocytoma.
    Grossman E; Goldstein DS; Hoffman A; Keiser HR
    Hypertension; 1991 Jun; 17(6 Pt 1):733-41. PubMed ID: 2045133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of an effect of mianserin on the actions of clonidine or methyldopa in hypertensive patients.
    Elliott HL; McLean K; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1983; 24(1):15-9. PubMed ID: 6299752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effects of prazosin and phenoxybenzamine on arterial pressure, heart rate and plasma catecolamines in essential arterial hypertension].
    Mulvihill-Wilson J; Graham RM; Pettinger WA; Muckleroy C; Anderson S; Gaffney F; Blomqvist CG
    Cardiology; 1980; 66 Suppl 2():85-93. PubMed ID: 6116543
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.
    Ito Y; Fujimoto Y; Obara T
    World J Surg; 1992; 16(4):759-63; discussion 763-4. PubMed ID: 1413846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
    Mitchell HC; Pettinger WA
    Clin Pharmacol Ther; 1981 Sep; 30(3):297-302. PubMed ID: 6115731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of the clonidine suppression test in the diagnosis of pheochromocytoma.
    Karlberg BE; Hedman L
    Acta Med Scand Suppl; 1986; 714():15-21. PubMed ID: 3472437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of clonidine on changes in plasma catecholamine concentrations and oxygen consumption caused by the cold pressor test.
    Taittonen MT; Aantaa R; Kirvelä OA
    Br J Anaesth; 1998 Aug; 81(2):140-4. PubMed ID: 9813511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
    Eisenhofer G; Goldstein DS; Walther MM; Friberg P; Lenders JW; Keiser HR; Pacak K
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2656-66. PubMed ID: 12788870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma.
    Plewe G; Krause U; Cordes U; Beyer J
    Klin Wochenschr; 1988 Sep; 66(17):764-7. PubMed ID: 3184760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.